Nanotechnologies to help in new cancer treatment strategy
ULISES is set to develop an immunologic-based treatment strategy where cancer cells are reprogrammed to become “visible” to the patients’ immune system.
According to the statistics from the World Health Organization, cancer is the second leading cause of death globally, counting for approximately 9.6 million deaths in 2018. This figure is expected to increase by 60% by 2040 due to the ageing and increase of the world’s population.
While cancer treatments are currently based on surgical resection of the tumour (if possible), chemotherapy, radiotherapy, target-driven therapies and immunotherapy, ULISES aims to set out an all-new therapeutic strategy based on nanotechnologies.
RT @EUeic: After 2 years, @FETFX_EU is coming to an 🔚 Before signing off, they have shared a video with testimonies from scientists & engi…
🩺This year’s #EuropeanCancerSummit will be on November 17th & 18th 🔍The focus will be on the implementation of #EUCancerPlan & #MissionCancer recommendations 📝You can find out more about the speakers and register here https://t.co/KGPJMtSmpU https://t.co/lmCj3FqrYE